Charles A. Dinarello
|Charles A. Dinarello|
Charles Dinarello, 2010
April 22, 1943 |
|Institutions||University of Colorado Denver|
|Alma mater||Yale University|
|Known for||Research on inflammatory cytokines|
|Notable awards||Paul Ehrlich and Ludwig Darmstaedter Prize (2010)
Crafoord Prize (2009)
Albany Medical Center Prize (2009)
Dinarello received his Doctor of Medicine in 1969 at Yale University and since 1996, he is Professor of Medicine at University of Colorado School of Medicine. He is also Professor of Experimental Medicine at the Radboud University Medical Center in Nijmegen, The Netherlands. Dinarello is considered one of the founding fathers of cytokines having purified and cloned interleukin-1. This important step established the validation of cytokines as mediators of disease, particularly of inflammation. Current studies blocking IL-1 in humans supports Dinarello's and his co-workers pivotal contributions to cytokine biology and the pathogenesis of inflammatory diseases.
He is fluent in English, Italian and German.
- 1993, Ernst Jung Prize
- The 2009 Albany Medical Center Prize (Shared with Ralph M. Steinman and Bruce A. Beutler)
- 2006, Hamdan Award for Medical Research Excellence, awarded by Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, Dubai, United Arab Emirates
- 2009, together with Tadamitsu Kishimoto and Toshio Hirano: Crafoord Prize in Polyarthritis for “for their pioneering work to isolate interleukins, determine their properties and explore their role in the onset of inflammatory diseases”.
- 2010: Paul Ehrlich and Ludwig Darmstaedter Prize
- 2010: Novartis Prize in Clinical Immunology together with Juerg Tschopp.
|Wikimedia Commons has media related to Charles A. Dinarello.|
|This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it.|